Provided that there is evidence that an active substance does not give rise to concern within the meaning of Article 28(1) of Regulation (EU) No 528/2012, the Commission may adopt a decision pursuant to that Article amending Annex I to that Regulation in the sense referred to in Article 1 of this Regulation where the Agency has submitted an opinion pursuant to:
Article 4(4) of this Regulation;
Article 8(4) of Regulation (EU) No 528/2012; or
one of the acts provided for by Article 89(1) of Regulation (EU) No 528/2012.